|
Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer |
Lowery WJ, Lowery AW, Barnett JC, Lopez MA, Lee PS, Secord AA, Havrilesky L |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Lowery WJ, Lowery AW, Barnett JC, Lopez MA, Lee PS, Secord AA, Havrilesky L. Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. Gynecologic Oncology 2013; 130(3): 426-430 Indexing Status Subject indexing assigned by NLM MeSH Antineoplastic Agents /therapeutic use; Cost-Benefit Analysis; Decision Support Techniques; Drug Resistance, Neoplasm; Emergency Service, Hospital /economics; Female; Hospitalization /economics; Humans; Neoplasm Metastasis; Odds Ratio; Ovarian Neoplasms /drug therapy /economics /pathology; Palliative Care /economics; Platinum Compounds /therapeutic use; Quality of Life; Quality-Adjusted Life Years; Terminal Care /economics AccessionNumber 22013025086 Date bibliographic record published 24/07/2013 |
|
|
|